Femara 2.5 mg is a non-steroidal aromatase inhibitor containing Letrozole, designed to reduce estrogen levels in postmenopausal women. This reduction helps inhibit the growth of hormone-sensitive tumors, making it a vital treatment for breast cancer.
Key Features
- Contains 2.5 mg of Letrozole per tablet.
- Non-steroidal aromatase inhibitor effective for hormone receptor-positive breast cancer.
- Pack of 30 tablets for extended use.
- Prescribed for postmenopausal women.
- Helps reduce estrogen synthesis.
- Used in adjuvant therapy for early-stage breast cancer.
